Head of SKZ Materials Development Research Group reappointed
At the beginning of the year, Dr. Andreas Köppel took over as head of the Materials Development Group at the SKZ Plastic…
At the beginning of the year, Dr. Andreas Köppel took over as head of the Materials Development Group at the SKZ Plastic…
Supply chain finance optimizes working capital and stabilizes trade. The 5th Supply Chain Finance Hub of the Technical U…
„Der ASEAN Plan of Action on Science, Technology and Innovation, kurz APASTI, ist eine hervorragende Blaupause für Europ…
Das Fraunhofer-Zentrum für Energiespeicher und Systeme ZESS steht für die Entwicklung von Systemlösungen für Energiespei…
Update covers data from 11 heavily pre-treated, last-line patients in Phase 1b dose expansion Cohort A treated with IMA2…
Apogenix, a biopharmaceutical company developing next generation immunotherapeutics, announced today that its partner CA…
Clinical validation of PRAME as multi-tumor target with large potential for TCR-based therapies: confirmed responses in…
IMA203CD8 is a 2nd-generation product candidate co-expressing Immatics’ proprietary CD8αβ co-receptor engaging funct…
Completion of enrolment in PARTNER clinical trial, comparing MagnetOs to autograft First patient treated with MagnetOs F…
Immatics N.V. (Nasdaq: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and develop…